30 April 2021

PrEP and TasP¨ modelling shows need for optimization

Gay, bisexual and other men who have sex with men (MSM) have been disproportionally affected by the HIV epidemic in British Columbia (BC). Since 2010, Treatment as Prevention¨ (TasP¨) has been adopted as a public health policy in BC to maximize health care engagement of people living with HIV and improve virologic suppression, and as a result, to reduce secondary new infections. However, TasP¨ has been relatively less responsive in reducing HIV transmission among MSM than in other populations in BC, which calls for further optimization and combination with other preventive strategies.

PrEP and TasP¨ modelling shows need for optimization Read More »

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below